Prepro-Atrial Natriuretic Factor (26-55) (human) represents a key intermediate segment used to study precursor processing and peptide maturation. The sequence captures structural motifs essential for folding and internal interaction mapping. Researchers employ this fragment to analyze biosynthetic pathways and molecular recognition elements. Its well-defined form aids in synthetic biology and peptide engineering investigations.
CAT No: A17053
CAS No:112160-82-4
Synonyms/Alias:112160-82-4;Prepro-Atrial Natriuretic Factor (26-55) (human);MFCD00167655;DA-57033;FP109501;Prepro-atrial natriuretic factor(26-55)(human);H-Asn-Pro-Met-Tyr-Asn-Ala-Val-Ser-Asn-Ala-Asp-Leu-Met-Asp-Phe-Lys-Asn-Leu-Leu-Asp-His-Leu-Glu-Glu-Lys-Met-Pro-Leu-Glu-Asp-OH; H-NPMY NAVSNADLMDFKNLLDHLEEKMPLED-OH;Prepro-Atrial Natriuretic Factor (26-55) (human) (H-Asn-Pro-Met-Tyr-Asn-Ala-Val-Ser-Asn-Ala-Asp-Leu-Met-Asp-Phe-Lys-Asn-Leu-Leu-Asp-His-Leu-Glu-Glu-Lys-Met-Pro-Leu-Glu-Asp-OH);
3. Peptides as Active Ingredients: A Challenge for Cosmeceutical Industry
5. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.